A woman in her fifties, Nicola McKay, who used a contraceptive injection for an extended period, attributes three significant brain tumors she now struggles with to the medication. She, along with many other women, links the Depo-Provera injection to brain tumors after consistent use. Nicola, residing in the Scottish Highlands, began receiving these injections in the early 2000s as a form of birth control.
Initially trusting the drug’s safety, Nicola now suspects it as the cause behind the discovery of three brain tumors by doctors last year. She expressed how her life has been drastically altered by these tumors, making her a different person from her previous active and outgoing self. Nicola, a nurse, emphasized the impact of these tumors, stating they affect every aspect of her life and have forced her to shift from care-giving to being cared for.
Despite medical intervention, Nicola’s tumors have not been entirely eradicated, with one only shrinking through radiotherapy. This ongoing presence means she will continue to experience repercussions, such as seizures, in the long run, necessitating ongoing medication. Among the group of about 150 women attributing their brain cancer to Depo-Provera, Trish Saunders, 45, from Aberdeen, underwent brain surgery after a meningioma tumor was detected behind her right eye.
A study published by the British Medical Journal in March 2024 indicated that prolonged use of the contraceptive injection heightens the risk of developing this specific type of cancer, which though usually nonmalignant, can lead to severe headaches, hearing loss, and seizures. Trish reflected on her experience, expressing that had she been aware of the potential for brain tumors, she would have reconsidered using the drug.
Thompsons Solicitors Scotland is currently investigating the claims from affected women, with over 200 individuals seeking legal assistance, and 150 having signed up for representation. These women recently addressed their challenges to lawmakers at the Scottish Parliament, urging for awareness and action. Pharmaceutical company Pfizer and the Medicines and Healthcare products Regulation Agency (MHRA) assured ongoing monitoring of Depo-Provera’s safety, with MHRA’s chief safety officer emphasizing a commitment to reviewing all available evidence for regulatory decisions.
Pfizer emphasized the importance of patient safety, highlighting their rigorous monitoring processes and the drug’s long history of global approval. They encouraged individuals to consult healthcare professionals if they have concerns or encounter any adverse effects from the medication.